Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations*

Author: Nair Kavita V.   Tang Boxiong   Bos Jill Van Den   Zhang Vicki   Saseen Joseph J.   Naim Ahmad   Rahman Mirza  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.25, Iss.2, 2009-02, pp. : 303-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content